Gelir payları three months ended June 30, 2026 dönemi için tahmindir; resmî bir bildirimden alınmış rakamlar değildir.
Routine and non-routine clinical laboratory tests
Tests of blood, urine and other samples, including common checks of blood counts, organ function, allergies and infections, as well as more specialized tests.
Advanced diagnostic tests
Specialized tests in areas such as cancer, genetics, brain health and autoimmune disease. Examples include blood tests for Alzheimer’s disease risk and Haystack testing for signs of remaining or returning cancer.
Anatomic pathology
Examination of tissue and cell samples to help diagnose cancer and other diseases.
Collaborative Lab Solutions
Services that help hospitals manage their laboratories, choose tests, control supply costs and use laboratory data.
QuestHealth.com
A website where people can buy health and wellness tests, with physician review of test orders and the option to discuss results with a physician.
ExamOne
Examinations, sample testing and information gathering that help life insurers assess insurance applicants.
Quest Diagnostics collects and tests blood, urine, tissue and other samples, then provides results that help healthcare professionals diagnose, monitor and treat medical conditions. It also performs tests that hospitals send to outside laboratories, helps hospitals run their own labs, and offers testing and data services to insurers and other organizations. It processed 244 million test requisitions (2025, high).
Quest Diagnostics Inc. şirketinin ABD Menkul Kıymetler ve Borsa Komisyonu’na (SEC) sunduğu kendi belgelerinden kuruldu. Rakamlar bildirildiği gibidir; hisse başına geçmiş bugünkü hisse tabanına göre yeniden hesaplanmıştır. Bu bir işletmeyi anlatır — yatırım tavsiyesi değildir ve alma ya da satma önerisi değildir.
The themes Quest Diagnostics is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
$259,69%0,013 Kas kapanış
30 Eylül 2026 tarihine kadarki rakamlar, 23 Ekim 2026 tarihinde sunulan 10-Q raporundan
Quest Diagnostics performs medical tests on blood and other samples for doctors, hospitals, health plans and patients.
Şirket öngörüsü: 2026 mali yılı için $12,1B ile $12,1B arası gelir — bir yıl öncesine göre %9,5 artış
Grade A
Fiyatın altındaki şerit, her tarihteki notu gösterir; yalnızca o tarihe kadar yayımlanmış belgelerden hesaplanır.
Quest Diagnostics Inc. şirketinin not geçmişinin 40 çeyreğinden 2 tanesi gösteriliyor. Diğer 38 çeyrek Şubat 2017 tarihine kadar uzanıyor.
